USPTO 2015–2025 USPTO PatentsView US Corporation

Prellis Biologics, Inc.

USPTO PatentsView assignee record - 6 granted patents across 12 technology areas, active 2019–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

24.7

Avg claims per patent

+400%

5-year filing velocity

The verdict

Prellis holds 6 US patents across 12 technology areas, rank #42,279 of 50,000 tracked assignees.

#42,279
of 50,000 US assignees by volume: Top 36%
by Innovation Score (40.4/100): 24.7
avg claims per patent: +400%
filing velocity, last 5 yrs

Portfolio overview

Prellis Biologics, Inc. has been granted 6 US utility patents between 2019 and 2024, placing Prellis Biologics, Inc. at rank #42,279 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.7 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Prellis Biologics, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Prellis sits between PPG Advanced Surface Technologies, Llc (6 patents, rank #42,275) and Primero Games, Llc (6 patents, rank #42,283) - the closest US assignees by grant volume. The composite Innovation Score of 40.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 1 in the 2015–2019 window, a +400% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Prellis Biologics, Inc.'s 24.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Prellis Biologics, Inc. against peers pursuing similar technology classes.

PPG Advanced Surf…

6
Precision Medical…

6
Precision Robotics

6
Precision TOOL

6
Premiata S R L

6
Premier Energy Ho…

6
Pressing Developm…

6
Primero Games

6
Prellis Biologics ◀

6

What this shows Prellis holds 6 patents at rank #42,279, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Prellis

By rank, the assignees closest to #42,279 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Prellis's primary technology class.

Prellis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Prellis Biologics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	16.7%
2021	2	33.3%
2023	1	16.7%
2024	2	33.3%

Which technologies does Prellis Biologics, Inc. patent most?

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 5

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 3

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 3

B33Y - ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING 3

C07K - PEPTIDES 2

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 2

B22F - WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER ; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER 2

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 2

C08F - MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 1

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 1

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 1

B29K - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR ; MOULDS, ; REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS 1

Top 12 of 12 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#42,279

Across all tracked assignees

Innovation Score

40.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Prellis Biologics, Inc. hold?

Prellis Biologics, Inc. holds 6 US granted patents filed between 2019 and 2024, spanning 12 technology areas.

What is Prellis Biologics, Inc.'s Innovation Score?

Prellis Biologics, Inc. has an Innovation Score of 40.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Prellis Biologics, Inc. focus on?

Prellis Biologics, Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 5 patents. The company has filed patents in 12 CPC subclasses total.

Is Prellis Biologics, Inc.'s patent filing rate increasing or decreasing?

Prellis Biologics, Inc.'s recent filing velocity is +400% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Prellis Biologics, Inc.'s patents?

Prellis Biologics, Inc.'s patents average 24.7 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Prellis Biologics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Prellis's 6 grants land it in the top 36% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Prellis ranks #42,279 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.